Empowerment — Empowerment Program for New Graduated Nurses
Citation(s)
Im SB, Cho MK, Kim SY, Heo ML The Huddling Programme: effects on empowerment, organisational commitment and ego-resilience in clinical nurses - a randomised trial. J Clin Nurs. 2016 May;25(9-10):1377-87. doi: 10.1111/jocn.13228. Epub 2016 Mar 16.
Laschinger HK, Finegan J, Shamian J The impact of workplace empowerment, organizational trust on staff nurses' work satisfaction and organizational commitment. Health Care Manage Rev. 2001 Summer;26(3):7-23. doi: 10.1097/00004010-200107000-00002.
Spence Laschinger HK, Nosko A, Wilk P, Finegan J Effects of unit empowerment and perceived support for professional nursing practice on unit effectiveness and individual nurse well-being: a time-lagged study. Int J Nurs Stud. 2014 Dec;51(12):1615-23. doi: 10.1016/j.ijnurstu.2014.04.010. Epub 2014 Apr 19.
Spreitzer, G M. Psychological empowerment in the workplace: Dimension, measurement, and validation. The Academy of Management Journal. 1995; 38(5): 1442-1465.
Evaluation of the Effectiveness of the Training Program Developed to Empower New Graduated Nurses
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
